FRIMED-Klinisk medisin og folkehelse
Hepatocyte Growth Factor (HGF)-signalling as target for treatment of multiple myeloma
Multiple myeloma is due to clonal expansion of malignant plasma cells. The incidence in the Nordic countries is approximately 6 new cases per 100,000 per year, which corresponds to nearly 20% of hematological cancers. Approximately 300 persons are given t his diagnosis each year in Norway. An imp...